Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Structural brain network fingerprints of focal dystonia.

Chirumamilla VC, Dresel C, Koirala N, Gonzalez-Escamilla G, Deuschl G, Zeuner KE, Muthuraman M, Groppa S.

Ther Adv Neurol Disord. 2019 Nov 16;12:1756286419880664. doi: 10.1177/1756286419880664. eCollection 2019.

2.

'Atypical' Parkinson's disease - sporadic.

Zeuner KE, Berg D.

Int Rev Neurobiol. 2019;149:195-206. doi: 10.1016/bs.irn.2019.10.002. Epub 2019 Nov 21.

PMID:
31779812
3.

Cognitive behavioral therapy in functional tremor: A promising treatment approach.

Zeuner KE, Sidiropoulos C.

Neurology. 2019 Nov 5;93(19):825-826. doi: 10.1212/WNL.0000000000008438. Epub 2019 Oct 4. No abstract available.

PMID:
31586024
4.

Functional movement disorders in neurogeriatric inpatients : Underdiagnosed, often comorbid to neurodegenerative disorders and treatable.

Mätzold S, Geritz J, Zeuner KE, Berg D, Paschen S, Hieke J, Sablowsky S, Ortlieb C, Bergmann P, Hofmann W, Espay AJ, Maetzler W.

Z Gerontol Geriatr. 2019 Jul;52(4):324-329. doi: 10.1007/s00391-019-01562-y. Epub 2019 May 28. Review.

PMID:
31139963
5.

Role of ANO3 mutations in dystonia: A large-scale mutational screening study.

Olschewski L, Jesús S, Kim HJ, Tunc S, Löns S, Junker J, Zeuner KE, Kühn AA, Kuhlenbäumer G, Schäffer E, Berg D, Kasten M, Ferbert A, Altenmüller E, Brüggemann N, Bauer P, Rolfs A, Jeon B, Bäumer T, Mir P, Klein C, Lohmann K.

Parkinsonism Relat Disord. 2019 May;62:196-200. doi: 10.1016/j.parkreldis.2018.12.030. Epub 2019 Jan 2.

PMID:
30712998
6.

Progress of Pharmacological Approaches in Parkinson's Disease.

Zeuner KE, Schäffer E, Hopfner F, Brüggemann N, Berg D.

Clin Pharmacol Ther. 2019 May;105(5):1106-1120. doi: 10.1002/cpt.1374. Epub 2019 Mar 22. Review.

PMID:
30661251
7.

Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.

Baumann A, Nebel A, Granert O, Giehl K, Wolff S, Schmidt W, Baasch C, Schmidt G, Witt K, Deuschl G, Hartwigsen G, Zeuner KE, van Eimeren T.

Neurorehabil Neural Repair. 2018 Dec;32(12):1055-1066. doi: 10.1177/1545968318812726. Epub 2018 Nov 16.

PMID:
30444176
8.

Dynamic causal modeling revealed dysfunctional effective connectivity in both, the cortico-basal-ganglia and the cerebello-cortical motor network in writers' cramp.

Rothkirch I, Granert O, Knutzen A, Wolff S, Gövert F, Pedersen A, Zeuner KE, Witt K.

Neuroimage Clin. 2018 Jan 28;18:149-159. doi: 10.1016/j.nicl.2018.01.015. eCollection 2018.

9.

Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias.

Hebert E, Borngräber F, Schmidt A, Rakovic A, Brænne I, Weissbach A, Hampf J, Vollstedt EJ, Größer L, Schaake S, Müller M, Manzoor H, Jabusch HC, Alvarez-Fischer D, Kasten M, Kostic VS, Gasser T, Zeuner KE, Kim HJ, Jeon B, Bauer P, Altenmüller E, Klein C, Lohmann K.

Genes (Basel). 2017 Oct 18;8(10). pii: E276. doi: 10.3390/genes8100276. Review.

10.

Frontal Lobe Connectivity and Network Community Characteristics are Associated with the Outcome of Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease.

Koirala N, Fleischer V, Glaser M, Zeuner KE, Deuschl G, Volkmann J, Muthuraman M, Groppa S.

Brain Topogr. 2018 Mar;31(2):311-321. doi: 10.1007/s10548-017-0597-4. Epub 2017 Oct 6.

PMID:
28986718
11.

Alcohol improves cerebellar learning deficit in myoclonus-dystonia: A clinical and electrophysiological investigation.

Weissbach A, Werner E, Bally JF, Tunc S, Löns S, Timmann D, Zeuner KE, Tadic V, Brüggemann N, Lang A, Klein C, Münchau A, Bäumer T.

Ann Neurol. 2017 Oct;82(4):543-553. doi: 10.1002/ana.25035. Epub 2017 Sep 25.

PMID:
28869676
12.

Gut microbiota in Parkinson disease in a northern German cohort.

Hopfner F, Künstner A, Müller SH, Künzel S, Zeuner KE, Margraf NG, Deuschl G, Baines JF, Kuhlenbäumer G.

Brain Res. 2017 Jul 15;1667:41-45. doi: 10.1016/j.brainres.2017.04.019. Epub 2017 May 12.

PMID:
28506555
13.

Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.

Hanganu A, Muthuraman M, Chirumamilla VC, Koirala N, Paktas B, Deuschl G, Zeuner KE, Groppa S.

PLoS One. 2017 Feb 13;12(2):e0172374. doi: 10.1371/journal.pone.0172374. eCollection 2017.

14.

Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.

Alexandru H, Muthuraman M, Chirumamilla VC, Koirala N, Paktas B, Deuschl G, Zeuner KE, Groppa S.

PLoS One. 2016 Dec 16;11(12):e0168652. doi: 10.1371/journal.pone.0168652. eCollection 2016. Erratum in: PLoS One. 2017 Feb 13;12 (2):e0172374.

15.

Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.

Zeuner KE, Knutzen A, Kühl C, Möller B, Hellriegel H, Margraf NG, Deuschl G, Stolze H.

Brain Inj. 2017;31(1):75-82. doi: 10.1080/02699052.2016.1218545. Epub 2016 Nov 23.

PMID:
27880052
16.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

17.

Dopamine DRD2 polymorphism (DRD2/ANNK1-Taq1A) is not a significant risk factor in writer's cramp.

Zeuner KE, Acewicz A, Knutzen A, Dressler D, Lohmann K, Witt K.

J Neurogenet. 2016 Sep - Dec;30(3-4):276-279. Epub 2016 Oct 4.

PMID:
27696930
18.

Early- and late-onset essential tremor patients represent clinically distinct subgroups.

Hopfner F, Ahlf A, Lorenz D, Klebe S, Zeuner KE, Kuhlenbäumer G, Deuschl G.

Mov Disord. 2016 Oct;31(10):1560-1566. doi: 10.1002/mds.26708.

PMID:
27384030
19.

Pharmacokinetics and pharmacodynamics of incobotulinumtoxinA influencing the clinical efficacy in post-stroke spasticity.

Zeuner KE, Deuschl G.

Expert Opin Drug Metab Toxicol. 2016;12(4):457-66. doi: 10.1517/17425255.2016.1152262. Epub 2016 Feb 29. Review.

PMID:
26882333
20.

The role of mutations in COL6A3 in isolated dystonia.

Lohmann K, Schlicht F, Svetel M, Hinrichs F, Zittel S, Graf J, Lohnau T, Schmidt A, Mir P, Krause P, Lang AE, Jabusch HC, Wolters A, Kamm C, Zeuner KE, Altenmüller E, Naz S, Chung SJ, Kostic VS, Münchau A, Kühn AA, Brüggemann N, Klein C.

J Neurol. 2016 Apr;263(4):730-4. doi: 10.1007/s00415-016-8046-y. Epub 2016 Feb 12.

PMID:
26872670

Supplemental Content

Loading ...
Support Center